Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06632158 · ClinicalTrials.gov registry record · Phase 2
Personal Relevance of Psychotherapy for Asian Americans
A Phase 2 study of Anxiety and Stress, sponsored by IRIS Media.
- Completed
- Registry status
- Phase 2
- Development phase
- 268
- Enrollment target
- 1
- Study location
NCT06632158 is a Phase 2 study of Anxiety and Stress that has completed, run by IRIS Media. The registered enrollment target is 268 participants, below the 439-participant average among 364 other Anxiety trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06632158, a Phase 2 study of Anxiety and Stress, has completed, sponsored by IRIS Media.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 268 participants
- Enrollment target
- 1
- Study location
Study Summary
Using a three-armed design the investigators will test whether participants in the Mindboba online application experience significantly greater improvements as compared to participants in the active control (online app based on Cognitive Behavioral Therapy) and participants in the business-as-usual control. The outcome measures are self-reported social problem-solving, self-efficacy, stress, depression, anxiety, attitudes towards seeking mental health, and knowledge.
Interventions
- BEHAVIORAL MindBoba
- BEHAVIORAL Mindshift CBT
Study Locations (1)
Oregon
- IrisEd dba Trifoia - Eugene
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 268 participants |
| Start Date | 2024-05-01 |
| Est. Completion | 2024-12-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06632158
The ClinicalTrials.gov registry entry for NCT06632158 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 268 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 439-participant average among 364 other Anxiety trials with a reported enrollment target (39% lower). The listed sponsor is IRIS Media, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Anxiety appearing as the primary indexed condition, and to 2 interventions - of which MindBoba is the first listed.
NCT06632158 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.
Frequently Asked Questions
What is clinical trial NCT06632158 about?
NCT06632158 is a clinical study titled "Personal Relevance of Psychotherapy for Asian Americans". Using a three-armed design the investigators will test whether participants in the Mindboba online application experience significantly greater improvements as compared to participants in the active control (online app based on Cognitive Behavioral Therapy) and participants in the business-as-usual ...
What is the current status of trial NCT06632158?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 268 participants. The study started on 2024-05-01. Estimated completion is 2024-12-30.
What conditions does trial NCT06632158 study?
This clinical trial studies the following conditions: Anxiety, Stress, Behavior.
What interventions are being tested in trial NCT06632158?
The interventions under investigation include: MindBoba (BEHAVIORAL), Mindshift CBT (BEHAVIORAL).
Who is sponsoring clinical trial NCT06632158?
This trial is sponsored by IRIS Media, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06632158 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women
RECRUITING · Phase 2
-
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors
RECRUITING · Phase 2
-
Personalized Brain Stimulation to Treat Chronic Concussive Symptoms
RECRUITING · Phase 2
-
Cannabidiol and Older Adult Cannabis Users
RECRUITING · Phase 2
-
Use of CBD in the Treatment of Anxiety
RECRUITING · Phase 2
-
Cannabis for Palliative Care in Cancer
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.